tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ron Squarer Joins Nuvalent Board as Independent Director
PremiumCompany AnnouncementsRon Squarer Joins Nuvalent Board as Independent Director
3M ago
Nuvalent initiated with a Buy at Truist
Premium
The Fly
Nuvalent initiated with a Buy at Truist
3M ago
Nuvalent Announces $500M Stock Offering Pricing
Premium
Company Announcements
Nuvalent Announces $500M Stock Offering Pricing
3M ago
Nuvalent price target raised to $158 from $112 at Baird
PremiumThe FlyNuvalent price target raised to $158 from $112 at Baird
3M ago
Nuvalent’s Neladalkib Shows Superior Efficacy and Safety in Clinical Trials
Premium
Ratings
Nuvalent’s Neladalkib Shows Superior Efficacy and Safety in Clinical Trials
3M ago
Nuvalent announces $500M Class A common stock offering
Premium
The Fly
Nuvalent announces $500M Class A common stock offering
3M ago
Nuvalent’s Neladalkib: Promising ALK+ NSCLC Treatment with Strong Phase 2 Data and De-risked Approval Path
PremiumRatingsNuvalent’s Neladalkib: Promising ALK+ NSCLC Treatment with Strong Phase 2 Data and De-risked Approval Path
3M ago
Nuvalent’s Promising Future: Buy Rating Backed by ALKOVE-1 Study Success and Strategic Growth Plans
Premium
Ratings
Nuvalent’s Promising Future: Buy Rating Backed by ALKOVE-1 Study Success and Strategic Growth Plans
3M ago
Nuvalent price target raised to $155 from $130 at H.C. Wainwright
Premium
The Fly
Nuvalent price target raised to $155 from $130 at H.C. Wainwright
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100